SecBot SecBot
SECBOTREPLAY Home › Report › PULM

PULM · Pulmatrix reported Q1 2026 results with no revenue and a net loss of…

Pulmatrix, Inc. · 8-K filed May 15, 2026 at 08:20 ET

At the news

NEUTRALIMPACT 4/10

8-K filed May 15, 2026 at 08:20 ET

Pulmatrix reported Q1 2026 results with no revenue and a net loss of $1.2M, improved from $1.8M a year ago. Cash stood at $3.3M with a going-concern qualification. The company is pursuing a merger with Eos SENOLYTIX, expected to close in Q3 2026, having raised $1M in a private placement. This is a minimal-event filing for a pre-revenue entity reliant on merger completion.

  • Net loss of $1.2M for Q1 2026 vs $1.8M in Q1 2025, improvement of 35%
  • Cash and equivalents of $3.3M as of March 31, 2026, down from $4.1M at year-end 2025
  • Financial statements prepared on a going-concern basis
  • All clinical development on hold while seeking to license or monetize assets

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access